| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | signaling adaptor activity | 1.40e-04 | 129 | 41 | 4 | GO:0035591 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 3.16e-04 | 13 | 41 | 2 | GO:0005078 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 6.88e-04 | 19 | 41 | 2 | GO:0031434 | |
| GeneOntologyMolecularFunction | RNA cap binding | 8.43e-04 | 21 | 41 | 2 | GO:0000339 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.22e-03 | 229 | 41 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | poly(A) binding | 1.61e-03 | 29 | 41 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.84e-03 | 31 | 41 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.96e-03 | 32 | 41 | 2 | GO:0140457 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 2.62e-03 | 37 | 41 | 2 | GO:0070717 | |
| Domain | DM15 | 4.03e-06 | 2 | 38 | 2 | SM00684 | |
| Domain | KSR1-SAM | 4.03e-06 | 2 | 38 | 2 | PF13543 | |
| Domain | DM15 | 4.03e-06 | 2 | 38 | 2 | IPR006607 | |
| Domain | KSR_SAM-like_dom | 4.03e-06 | 2 | 38 | 2 | IPR025561 | |
| Domain | NUT | 4.02e-05 | 5 | 38 | 2 | IPR024310 | |
| Domain | NUT_N | 4.02e-05 | 5 | 38 | 2 | IPR024309 | |
| Domain | NUT | 4.02e-05 | 5 | 38 | 2 | PF12881 | |
| Domain | La | 8.41e-05 | 7 | 38 | 2 | PF05383 | |
| Domain | Lupus_La_RNA-bd | 8.41e-05 | 7 | 38 | 2 | IPR006630 | |
| Domain | LA | 8.41e-05 | 7 | 38 | 2 | SM00715 | |
| Domain | HTH_LA | 8.41e-05 | 7 | 38 | 2 | PS50961 | |
| Domain | EPHD | 9.08e-04 | 22 | 38 | 2 | PS51805 | |
| Domain | C1_1 | 6.00e-03 | 57 | 38 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 7.51e-03 | 64 | 38 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 7.51e-03 | 64 | 38 | 2 | PS50081 | |
| Domain | C1 | 7.73e-03 | 65 | 38 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 7.97e-03 | 66 | 38 | 2 | IPR002219 | |
| Domain | SAM_1 | 8.44e-03 | 68 | 38 | 2 | PF00536 | |
| Domain | Ank_2 | 9.44e-03 | 215 | 38 | 3 | PF12796 | |
| Domain | PHD | 1.02e-02 | 75 | 38 | 2 | PF00628 | |
| Domain | Ank | 1.11e-02 | 228 | 38 | 3 | PF00023 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 2.30e-07 | 108 | 43 | 5 | 19531213 | |
| Pubmed | 3.02e-07 | 114 | 43 | 5 | 31553912 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 8.88e-07 | 861 | 43 | 9 | 36931259 | |
| Pubmed | Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK. | 1.49e-06 | 2 | 43 | 2 | 22801368 | |
| Pubmed | KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. | 1.49e-06 | 2 | 43 | 2 | 19883615 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 28180061 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.59e-06 | 678 | 43 | 8 | 30209976 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.07e-06 | 954 | 43 | 9 | 36373674 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 22456610 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 20945381 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 25636512 | ||
| Pubmed | KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. | 4.48e-06 | 3 | 43 | 2 | 19560418 | |
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 4.48e-06 | 3 | 43 | 2 | 26542179 | |
| Pubmed | The KSR2-calcineurin complex regulates STIM1-ORAI1 dynamics and store-operated calcium entry (SOCE). | 1.49e-05 | 5 | 43 | 2 | 24672054 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.14e-05 | 462 | 43 | 6 | 31138677 | |
| Pubmed | 2.20e-05 | 274 | 43 | 5 | 34244482 | ||
| Pubmed | HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data. | 2.23e-05 | 6 | 43 | 2 | 27086506 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 19351956 | ||
| Pubmed | 2.51e-05 | 713 | 43 | 7 | 29802200 | ||
| Pubmed | MEK drives BRAF activation through allosteric control of KSR proteins. | 3.12e-05 | 7 | 43 | 2 | 29433126 | |
| Pubmed | 3.76e-05 | 1371 | 43 | 9 | 36244648 | ||
| Pubmed | 4.42e-05 | 55 | 43 | 3 | 27997827 | ||
| Pubmed | 4.55e-05 | 529 | 43 | 6 | 14621295 | ||
| Pubmed | 5.70e-05 | 551 | 43 | 6 | 34728620 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 9.16e-05 | 370 | 43 | 5 | 22922362 | |
| Pubmed | 1.67e-04 | 223 | 43 | 4 | 33731348 | ||
| Pubmed | 1.73e-04 | 971 | 43 | 7 | 33306668 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.85e-04 | 430 | 43 | 5 | 35044719 | |
| Pubmed | 2.01e-04 | 234 | 43 | 4 | 36243803 | ||
| Pubmed | 2.07e-04 | 441 | 43 | 5 | 31239290 | ||
| Pubmed | 2.17e-04 | 239 | 43 | 4 | 26641092 | ||
| Pubmed | 2.19e-04 | 446 | 43 | 5 | 24255178 | ||
| Pubmed | Recruitment of the human TREX complex to mRNA during splicing. | 2.80e-04 | 20 | 43 | 2 | 15998806 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.91e-04 | 258 | 43 | 4 | 37794589 | |
| Pubmed | 3.20e-04 | 1429 | 43 | 8 | 35140242 | ||
| Pubmed | 3.24e-04 | 486 | 43 | 5 | 20936779 | ||
| Pubmed | 3.40e-04 | 22 | 43 | 2 | 22305495 | ||
| Pubmed | 3.72e-04 | 23 | 43 | 2 | 9143490 | ||
| Pubmed | 3.80e-04 | 503 | 43 | 5 | 36217030 | ||
| Pubmed | 4.03e-04 | 1116 | 43 | 7 | 31753913 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.49e-04 | 807 | 43 | 6 | 22681889 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 5.65e-04 | 130 | 43 | 3 | 35545047 | |
| Pubmed | 5.79e-04 | 847 | 43 | 6 | 35850772 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 6.95e-04 | 877 | 43 | 6 | 20211142 | |
| Pubmed | 7.23e-04 | 32 | 43 | 2 | 19542561 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 7.25e-04 | 329 | 43 | 4 | 34316702 | |
| Pubmed | 7.50e-04 | 332 | 43 | 4 | 25693804 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 7.69e-04 | 33 | 43 | 2 | 22357600 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 8.74e-04 | 605 | 43 | 5 | 28977666 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 9.01e-04 | 922 | 43 | 6 | 27609421 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 9.42e-04 | 353 | 43 | 4 | 27545878 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.02e-03 | 361 | 43 | 4 | 30344098 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.02e-03 | 361 | 43 | 4 | 26167880 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 1.06e-03 | 364 | 43 | 4 | 24778252 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.08e-03 | 1318 | 43 | 7 | 30463901 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.09e-03 | 163 | 43 | 3 | 22113938 | |
| Pubmed | 1.13e-03 | 963 | 43 | 6 | 28671696 | ||
| Pubmed | 1.13e-03 | 371 | 43 | 4 | 15747579 | ||
| Pubmed | 1.19e-03 | 168 | 43 | 3 | 39066279 | ||
| Pubmed | Spatially dependent dynamic MAPK modulation by the Nde1-Lis1-Brap complex patterns mammalian CNS. | 1.19e-03 | 41 | 43 | 2 | 23673330 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.23e-03 | 170 | 43 | 3 | 23314748 | |
| Interaction | YWHAH interactions | SLAIN2 LARP1 SRRM1 KSR1 RBM15 LARP1B PAN3 SIPA1 NCKAP5L CASKIN2 SMTNL2 KSR2 | 1.62e-06 | 1102 | 42 | 12 | int:YWHAH |
| Interaction | YWHAG interactions | SLAIN2 LARP1 SRRM1 KSR1 RBM15 LARP1B PAN3 SIPA1 NCKAP5L CASKIN2 SMTNL2 KSR2 | 5.87e-06 | 1248 | 42 | 12 | int:YWHAG |
| Cytoband | 10q23.2 | 1.16e-04 | 17 | 43 | 2 | 10q23.2 | |
| Cytoband | 10q22.3 | 7.55e-04 | 43 | 43 | 2 | 10q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 9.90e-04 | 208 | 43 | 3 | chr10q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q28 | 2.65e-03 | 81 | 43 | 2 | chr4q28 | |
| Cytoband | 17q11.2 | 4.82e-03 | 110 | 43 | 2 | 17q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 6.92e-03 | 415 | 43 | 3 | chr12q24 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.28e-05 | 5 | 21 | 2 | 1157 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 2.69e-05 | 7 | 21 | 2 | 625 | |
| GeneFamily | Ankyrin repeat domain containing | 2.64e-03 | 242 | 21 | 3 | 403 | |
| GeneFamily | Sterile alpha motif domain containing | 4.63e-03 | 88 | 21 | 2 | 760 | |
| GeneFamily | PDZ domain containing | 1.33e-02 | 152 | 21 | 2 | 1220 | |
| Computational | Neighborhood of CBFB | 2.17e-05 | 30 | 20 | 3 | GNF2_CBFB | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A | 1.44e-06 | 199 | 41 | 6 | 1739_UP | |
| Disease | Endometrial Stromal Sarcoma | 1.79e-05 | 5 | 40 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 2.68e-05 | 6 | 40 | 2 | C0334488 | |
| Disease | Antihypertensive use measurement | 2.86e-05 | 265 | 40 | 5 | EFO_0009927 | |
| Disease | monocyte count | 5.44e-05 | 1320 | 40 | 9 | EFO_0005091 | |
| Disease | platelet component distribution width | 6.24e-05 | 755 | 40 | 7 | EFO_0007984 | |
| Disease | event free survival time, type 1 diabetes mellitus, autoantibody measurement | 1.17e-04 | 12 | 40 | 2 | EFO_0000482, EFO_0004866, MONDO_0005147 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.86e-04 | 15 | 40 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 2.12e-04 | 16 | 40 | 2 | EFO_0004792, HP_0002140 | |
| Disease | factor XI measurement, Ischemic stroke | 2.41e-04 | 17 | 40 | 2 | EFO_0004694, HP_0002140 | |
| Disease | lymphocyte percentage of leukocytes | 2.56e-04 | 665 | 40 | 6 | EFO_0007993 | |
| Disease | factor VIII measurement, Ischemic stroke | 3.02e-04 | 19 | 40 | 2 | EFO_0004630, HP_0002140 | |
| Disease | inflammatory bowel disease | 3.39e-04 | 449 | 40 | 5 | EFO_0003767 | |
| Disease | monocyte percentage of leukocytes | 4.24e-04 | 731 | 40 | 6 | EFO_0007989 | |
| Disease | mean arterial pressure | 5.47e-04 | 499 | 40 | 5 | EFO_0006340 | |
| Disease | systemic lupus erythematosus | 6.77e-04 | 799 | 40 | 6 | MONDO_0007915 | |
| Disease | Ischemic stroke, factor VII measurement | 7.11e-04 | 29 | 40 | 2 | EFO_0004619, HP_0002140 | |
| Disease | response to angiotensin receptor blocker | 7.61e-04 | 30 | 40 | 2 | EFO_0010735 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 7.61e-04 | 30 | 40 | 2 | EFO_0004629, HP_0002140 | |
| Disease | coronary artery disease | 1.01e-03 | 1194 | 40 | 7 | EFO_0001645 | |
| Disease | bipolar disorder | 1.05e-03 | 577 | 40 | 5 | MONDO_0004985 | |
| Disease | neutrophil percentage of leukocytes | 1.34e-03 | 610 | 40 | 5 | EFO_0007990 | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 1.35e-03 | 40 | 40 | 2 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.59e-03 | 170 | 40 | 3 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | breast cancer (is_marker_for) | 2.02e-03 | 185 | 40 | 3 | DOID:1612 (is_marker_for) | |
| Disease | health study participation | 2.35e-03 | 195 | 40 | 3 | EFO_0010130 | |
| Disease | mean platelet volume | 2.36e-03 | 1020 | 40 | 6 | EFO_0004584 | |
| Disease | peripheral arterial disease | 2.45e-03 | 54 | 40 | 2 | EFO_0004265 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 2.45e-03 | 54 | 40 | 2 | EFO_0006336, EFO_0007878 | |
| Disease | comparative body size at age 10, self-reported | 2.47e-03 | 420 | 40 | 4 | EFO_0009819 | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.54e-03 | 55 | 40 | 2 | EFO_0004623, HP_0002140 | |
| Disease | Crohn's disease | 2.94e-03 | 441 | 40 | 4 | EFO_0000384 | |
| Disease | lymphocyte count | 3.22e-03 | 1464 | 40 | 7 | EFO_0004587 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 3.32e-03 | 63 | 40 | 2 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.32e-03 | 63 | 40 | 2 | EFO_0001645, EFO_0004792 | |
| Disease | cardiovascular disease | 3.34e-03 | 457 | 40 | 4 | EFO_0000319 | |
| Disease | rheumatoid arthritis | 3.47e-03 | 462 | 40 | 4 | EFO_0000685 | |
| Disease | sclerosing cholangitis | 3.64e-03 | 66 | 40 | 2 | EFO_0004268 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.20e-03 | 71 | 40 | 2 | EFO_0001645, EFO_0004791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPLHRNRRHPRSPPR | 166 | Q6UY14 | |
| VRRRHTPAPTRPRKP | 51 | Q2NKX9 | |
| PKKRNRHRCSSPPPP | 371 | Q9Y2G4 | |
| RPRKRHCAPSPDRSP | 661 | Q96T37 | |
| KRSRRRPLLPPTPDS | 371 | Q8NBR0 | |
| GRRRNSLPPSHQKPP | 86 | O00763 | |
| EKLASRPTRPPEPRH | 266 | Q6PKG0 | |
| ARPPPLTKVPRRAHT | 1161 | Q9HCH0 | |
| SRPRKPPPRKHTRSW | 231 | Q96AG4 | |
| PRLSPKTHRPRSPRQ | 681 | Q99700 | |
| PPHRRPTLHRRPTLP | 351 | Q5HYC2 | |
| SPRQRHAVRTPPRTP | 251 | Q6VAB6 | |
| GPPTRKPPRRTSSHL | 641 | Q9NQC1 | |
| QLRRHTKLKPPRTPP | 276 | Q8IVT5 | |
| RRHPLGRPPTRSPLS | 611 | O94953 | |
| TPPRSVPRLRPRHRH | 31 | P13985 | |
| PPRPKRRSHSLSRPG | 791 | Q8WXE0 | |
| SPKITPHTSPAPRRR | 346 | Q58A45 | |
| PLHTRPRVPAPKTRN | 821 | Q6UXX5 | |
| ALPRRRPRRHPSVNP | 41 | P09038 | |
| RQTPSRQPPLPHRSR | 31 | Q07666 | |
| PRHRPLNRTQSAPLP | 441 | Q9UKV0 | |
| PRPSVPRTLPGSRHK | 266 | Q9BTV7 | |
| PRRRLLPPTPASHRR | 1906 | Q01668 | |
| IHPTRTPKTPRTPRL | 596 | Q659C4 | |
| TRRRNPPPRTLHPIS | 416 | Q96BN6 | |
| TRRPPAKPRRHPSTK | 111 | Q6ZVC0 | |
| PPPRPHRRAETKARL | 481 | Q8IVF1 | |
| HRRAETKARLPPPRP | 486 | Q8IVF1 | |
| PPPRPHRRAETKARL | 481 | A6NNL0 | |
| HRRAETKARLPPPRP | 486 | A6NNL0 | |
| PRPHRRAETKARLPP | 411 | Q5VT03 | |
| PPPQPHRRAETKARL | 481 | B1AL46 | |
| HRRAETKARLPPPRP | 486 | B1AL46 | |
| EPPLAPPHRRRRSRQ | 106 | Q5VWQ0 | |
| RPSPKQSPRNSPRSR | 351 | Q9P270 | |
| RKLRQPARPPLTPHT | 26 | Q96FS4 | |
| TPPPRLLPRNTFSRK | 346 | Q9NT68 | |
| TQRRRRSKSPVLHPP | 76 | Q9NX31 | |
| SPPAARRSLLHRLPP | 1436 | Q9Y566 | |
| SPQPRLPPSRHPSRR | 81 | Q8TAI1 | |
| QRRYSPSPPPKRRTA | 601 | Q8IYB3 | |
| PKRRVSHSPPPKQRS | 631 | Q8IYB3 | |
| RKPRTLRHLPRTPRP | 166 | Q8N1W2 | |
| PRPRPVSLSLRLPHQ | 181 | Q2TAL5 | |
| RPRNKRRHVTLPSSP | 2706 | Q5T4S7 | |
| RLTSPLRPPKSSRPR | 161 | Q6AW86 | |
| SMPSPRLQHSKPPRR | 36 | P50539 |